Literature DB >> 24616366

Phenotype and polarization of autologous T cells by biomaterial-treated dendritic cells.

Jaehyung Park1, Michael H Gerber, Julia E Babensee.   

Abstract

Given the central role of dendritic cells (DCs) in directing T-cell phenotypes, the ability of biomaterial-treated DCs to dictate autologous T-cell phenotype was investigated. In this study, we demonstrate that differentially biomaterial-treated DCs differentially directed autologous T-cell phenotype and polarization, depending on the biomaterial used to pretreat the DCs. Immature DCs (iDCs) were derived from human peripheral blood monocytes and treated with biomaterial films of alginate, agarose, chitosan, hyaluronic acid, or 75:25 poly(lactic-co-glycolic acid) (PLGA), followed by co-culture of these biomaterial-treated DCs and autologous T cells. When autologous T cells were co-cultured with DCs treated with biomaterial film/antigen (ovalbumin, OVA) combinations, different biomaterial films induced differential levels of T-cell marker (CD4, CD8, CD25, CD69) expression, as well as differential cytokine profiles [interferon (IFN)-γ, interleukin (IL)-12p70, IL-10, IL-4] in the polarization of T helper (Th) types. Dendritic cells treated with agarose films/OVA induced CD4+CD25+FoxP3+ (T regulatory cells) expression, comparable to untreated iDCs, on autologous T cells in the DC-T co-culture system. Furthermore, in this co-culture, agarose treatment induced release of IL-12p70 and IL-10 at higher levels as compared with DC treatment with other biomaterial films/OVA, suggesting Th1 and Th2 polarization, respectively. Dendritic cells treated with PLGA film/OVA treatment induced release of IFN-γ at higher levels compared with that observed for co-cultures with iDCs or DCs treated with all other biomaterial films. These results indicate that DC treatment with different biomaterial films has potential as a tool for immunomodulation by directing autologous T-cell responses.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  T cells; biomaterial; dendritic cells; immunotherapy; polarization

Mesh:

Substances:

Year:  2014        PMID: 24616366      PMCID: PMC4160432          DOI: 10.1002/jbm.a.35150

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  89 in total

1.  Class I-restricted presentation of exogenous antigen acquired by Fcgamma receptor-mediated endocytosis is regulated in dendritic cells.

Authors:  P Machy; K Serre; L Leserman
Journal:  Eur J Immunol       Date:  2000-03       Impact factor: 5.532

2.  Ex vivo allogeneic stimulation significantly improves expansion of cytokine-induced killer cells without increasing their alloreactivity across HLA barriers.

Authors:  Maja Todorovic; Giulia Mesiano; Loretta Gammaitoni; Valeria Leuci; Lidia Giraudo Diego; Cristina Cammarata; Noela Jordaney; Fabrizio Carnevale-Schianca; Susanna Gallo; Franca Fagioli; Wanda Piacibello; Angela Rita Elia; Ymera Pignochino; Carmine Dell'aglio; Giovanni Grignani; Alessandro Cignetti; Massimo Aglietta; Dario Sangiolo
Journal:  J Immunother       Date:  2012-09       Impact factor: 4.456

3.  Development of a bioartificial pancreas: II. Effects of oxygen on long-term entrapped betaTC3 cell cultures.

Authors:  K K Papas; R C Long; A Sambanis; I Constantinidis
Journal:  Biotechnol Bioeng       Date:  1999       Impact factor: 4.530

4.  Differential functional effects of biomaterials on dendritic cell maturation.

Authors:  Jaehyung Park; Julia E Babensee
Journal:  Acta Biomater       Date:  2012-06-12       Impact factor: 8.947

5.  Quantitative analysis of the CD4 T-cell repertoire specific to therapeutic antibodies in healthy donors.

Authors:  Stephanie Delluc; Gilles Ravot; Bernard Maillere
Journal:  FASEB J       Date:  2011-03-02       Impact factor: 5.191

6.  Articular cartilage repair in rabbits by using suspensions of allogenic chondrocytes in alginate.

Authors:  E Fragonas; M Valente; M Pozzi-Mucelli; R Toffanin; R Rizzo; F Silvestri; F Vittur
Journal:  Biomaterials       Date:  2000-04       Impact factor: 12.479

7.  Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity.

Authors:  Keli L Hippen; Sarah C Merkel; Dawn K Schirm; Christine M Sieben; Darin Sumstad; Diane M Kadidlo; David H McKenna; Jonathan S Bromberg; Bruce L Levine; James L Riley; Carl H June; Phillip Scheinberg; Daniel C Douek; Jeffrey S Miller; John E Wagner; Bruce R Blazar
Journal:  Sci Transl Med       Date:  2011-05-18       Impact factor: 17.956

8.  Profiles of carbohydrate ligands associated with adsorbed proteins on self-assembled monolayers of defined chemistries.

Authors:  Sucharita P Shankar; Inn Inn Chen; Benjamin G Keselowsky; Andrés J García; Julia E Babensee
Journal:  J Biomed Mater Res A       Date:  2010-03-15       Impact factor: 4.396

9.  Distribution and compartmentalization of human circulating and tissue-resident memory T cell subsets.

Authors:  Taheri Sathaliyawala; Masaru Kubota; Naomi Yudanin; Damian Turner; Philip Camp; Joseph J C Thome; Kara L Bickham; Harvey Lerner; Michael Goldstein; Megan Sykes; Tomoaki Kato; Donna L Farber
Journal:  Immunity       Date:  2012-12-20       Impact factor: 31.745

10.  Dendritic cells control CD4+CD25+ Treg cell suppressor function in vitro through juxtacrine delivery of IL-2.

Authors:  Katarina Kulhankova; Todd Rouse; Mohamed E Nasr; Elizabeth H Field
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

View more
  9 in total

1.  Controlled Release of Second Generation mTOR Inhibitors to Restrain Inflammation in Primary Immune Cells.

Authors:  Emily A Gosselin; Lisa H Tostanoski; Christopher M Jewell
Journal:  AAPS J       Date:  2017-05-08       Impact factor: 4.009

Review 2.  Using immunotherapy to boost the abscopal effect.

Authors:  Wilfred Ngwa; Omoruyi Credit Irabor; Jonathan D Schoenfeld; Jürgen Hesser; Sandra Demaria; Silvia C Formenti
Journal:  Nat Rev Cancer       Date:  2018-02-16       Impact factor: 60.716

Review 3.  Biomaterial strategies for generating therapeutic immune responses.

Authors:  Sean H Kelly; Lucas S Shores; Nicole L Votaw; Joel H Collier
Journal:  Adv Drug Deliv Rev       Date:  2017-04-25       Impact factor: 15.470

Review 4.  Local delivery strategies to restore immune homeostasis in the context of inflammation.

Authors:  Elizabeth R Bentley; Steven R Little
Journal:  Adv Drug Deliv Rev       Date:  2021-09-13       Impact factor: 15.470

Review 5.  Biomaterial Strategies for Immunomodulation.

Authors:  Nathan A Hotaling; Li Tang; Darrell J Irvine; Julia E Babensee
Journal:  Annu Rev Biomed Eng       Date:  2015-09-29       Impact factor: 9.590

Review 6.  Biomaterials: Foreign Bodies or Tuners for the Immune Response?

Authors:  Erminia Mariani; Gina Lisignoli; Rosa Maria Borzì; Lia Pulsatelli
Journal:  Int J Mol Sci       Date:  2019-02-01       Impact factor: 5.923

7.  An Immunological Approach to the Biocompatibility of Mesoporous SiO2-CaO Nanospheres.

Authors:  María Montes-Casado; Adrian Sanvicente; Laura Casarrubios; María José Feito; José M Rojo; María Vallet-Regí; Daniel Arcos; Pilar Portolés; María Teresa Portolés
Journal:  Int J Mol Sci       Date:  2020-11-05       Impact factor: 5.923

8.  Impact of Excipients on Stability of Polymer Microparticles for Autoimmune Therapy.

Authors:  Emily A Gosselin; Maeesha Noshin; Sheneil K Black; Christopher M Jewell
Journal:  Front Bioeng Biotechnol       Date:  2021-02-11

Review 9.  Three-dimensional (3D) scaffolds as powerful weapons for tumor immunotherapy.

Authors:  Shuyan Han; Jun Wu
Journal:  Bioact Mater       Date:  2022-01-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.